Recent case law further clarifying patent subject matter eligibility under § 101 provides useful guidance for addressing claim rejections and, ultimately, securing robust patent claims in the life sciences. As the currently-published § 101 guidelines used by the USPTO do not utilize these recent clarifications, an understanding of the recent clarifications can be helpful to patent applicants. The following provides a backdrop to the evolution of the law under § 101 and its application in the life sciences area, and ...
Continue Reading →MAR
2018